UK markets open in 4 hours 56 minutes

Excelsior Biopharma Inc. (6496.TWO)

Taipei Exchange - Taipei Exchange Delayed price. Currency in TWD
Add to watchlist
28.000.00 (0.00%)
As of 12:14PM CST. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-91,011
-91,011
-33,757
-15,649
35,300
Depreciation & amortisation
46,215
46,215
26,060
28,648
27,369
Stock-based compensation
262
262
37
0
-
Change in working capital
-97,945
-97,945
16,031
32,611
459,067
Inventory
-28,702
-28,702
16,021
71,876
139,884
Other working capital
-170,407
-170,407
-2,297
52,946
509,198
Other non-cash items
1,124
1,124
-878
3,989
1,688
Net cash provided by operating activities
-134,750
-134,750
5,486
55,823
520,814
Cash flows from investing activities
Investments in property, plant and equipment
-35,657
-35,657
-7,783
-2,877
-11,616
Purchases of investments
-
-
0
-5,829
-4,752
Sales/maturities of investments
199,742
199,742
-200,000
-176
36,931
Other investing activities
-17,467
-17,467
8,539
-1,797
6,370
Net cash used for investing activities
146,618
146,618
-199,244
-10,679
26,936
Net change in cash
-305,358
-305,358
-207,486
-37,898
791,262
Cash at beginning of period
895,276
895,276
1,102,762
1,140,660
349,398
Cash at end of period
589,918
589,918
895,276
1,102,762
1,140,660
Free cash flow
Operating cash flow
-134,750
-134,750
5,486
55,823
520,814
Capital expenditure
-35,657
-35,657
-7,783
-2,877
-11,616
Free cash flow
-170,407
-170,407
-2,297
52,946
509,198